CREATE (Community deRivEd AutomaTEd insulin delivery) trial. Randomised parallel arm open label clinical trial comparing automated insulin delivery using a mobile controller (AnyDANA-loop) with an open-source algorithm with sensor augmented pump therapy in type 1 diabetes

BACKGROUND: Commercialised automated insulin delivery (AID) systems have demonstrated improved outcomes in type 1 diabetes (T1D), however, they have limited capacity for algorithm individualisation, and can be prohibitively expensive if an individual is without access to health insurance or health f...

Descripción completa

Detalles Bibliográficos
Autores principales: Burnside, M., Lewis, D., Crocket, H., Wilson, R., Williman, J., Jefferies, C., Paul, R., Wheeler, B. J., de Bock, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261211/
https://www.ncbi.nlm.nih.gov/pubmed/32837953
http://dx.doi.org/10.1007/s40200-020-00547-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261211/
https://www.ncbi.nlm.nih.gov/pubmed/32837953
http://dx.doi.org/10.1007/s40200-020-00547-8

Ejemplares similares